Cargando…

Clinical outcomes of low and intermediate risk differentiated thyroid cancer patients treated with 30mCi for ablation or without radioactive iodine therapy

OBJECTIVE: To retrospectively evaluate the outcomes of patients with low and intermediate risk thyroid carcinoma treated with total thyroidectomy (TT) and who did not undergo radioiodine remnant ablation (RRA) and to compare them to patients receiving low dose of iodine (30 mCi). SUBJECTS AND METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Súss, Shirlei Kugler Aiçar, Mesa, Cleo Otaviano, de Carvalho, Gisah Amaral, Miasaki, Fabíola Yukiko, Chaves, Carolina Perez, Fuser, Dominique Cochat, Corbo, Rossana, Momesso, Denise, Bulzico, Daniel A., Graf, Hans, Vaisman, Fernanda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Endocrinologia e Metabologia 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118992/ https://www.ncbi.nlm.nih.gov/pubmed/29641738 http://dx.doi.org/10.20945/2359-3997000000025

Ejemplares similares

Is radioactive iodine- ( 131 ) treatment related to the occurrence of non-synchronous second primary malignancy in patients with differentiated thyroid cancer?
por: de Souza, Marcelo Cruzick, et al.
Publicado: (2015)

Metastatic lymph node characteristics as predictors of recurrence/persistence in the neck and distant metastases in differentiated thyroid cancer
por: Barbosa, Mayara Peres, et al.
Publicado: (2017)

Thyroid Lobectomy Is Associated with Excellent Clinical Outcomes in Properly Selected Differentiated Thyroid Cancer Patients with Primary Tumors Greater Than 1 cm
por: Vaisman, Fernanda, et al.
Publicado: (2013)

Treatment of hypothyroidism with levothyroxine plus liothyronine: a randomized, double-blind, crossover study
por: Kaminski, Juliana, et al.
Publicado: (2016)

Genetic Mutations and Variants in the Susceptibility of Familial Non-Medullary Thyroid Cancer
por: Miasaki, Fabíola Yukiko, et al.
Publicado: (2020)

Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation
por: Jeon, Eon Ju, et al.
Publicado: (2014)

Pregnancy has no significant impact on the prognosis of differentiated thyroid cancer
por: Nobre, Gabriela Maia, et al.
Publicado: (2021)

Thyroid Carcinoma in Children and Adolescents—Systematic Review of the Literature
por: Vaisman, Fernanda, et al.
Publicado: (2011)

ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology
por: Barbosa, Thayse Lozovoy Madsen, et al.
Publicado: (2019)

Prognostic factors of a good response to initial therapy in children and adolescents with differentiated thyroid cancer
por: Vaisman, Fernanda, et al.
Publicado: (2011)

Puberty and sex in pediatric thyroid cancer: could expression of estrogen and progesterone receptors affect prognosis?
por: da Silva Breder, Julia Ramalho Amalio, et al.
Publicado: (2022)

Fixed 30 mCi (1110 MBq) (131)I-iodine therapy in autonomously functioning nodules: Single toxic nodule as a predictive factor of success
por: Pereira, Lívia Stela Bueno, et al.
Publicado: (2021)

Outcomes following I-131 treatment with cumulative dose exceeding or equal to 600 mCi in differentiated thyroid carcinoma patients
por: Kaewput, Chalermrat, et al.
Publicado: (2020)

Neuropsychological comparison of incident MCI and prevalent MCI
por: Hansen, Allison, et al.
Publicado: (2018)

Prognostic factors in patients with advanced differentiated thyroid cancer treated with multikinase inhibitors – a single Brazilian center experience
por: Treistman, Natalia, et al.
Publicado: (2021)

Feasibility and long-term results of focused radioguided parathyroidectomy using a "low" 37 MBq (1 mCi) (99m)Tc-sestamibi protocol
por: Rubello, Domenico, et al.
Publicado: (2006)

Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi
por: Kukulska, Aleksandra, et al.
Publicado: (2010)

Predictive value of pyramidal lobe, percentage thyroid uptake and age for ablation outcome after 15 mCi fixed dose of radioiodine-131 in Graves’ disease
por: Zaman, Maseeh uz, et al.
Publicado: (2015)

30 mCi exploratory scan for two-step dosimetric (131)I therapy in differentiated thyroid cancer patients: A novel approach and case report
por: Wu, Di, et al.
Publicado: (2020)

Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer – a prospective comparison of long-term outcomes
por: Kukulska, Aleksandra, et al.
Publicado: (2020)

Response: Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation (Endocrinol Metab 2014;29:33-9, Eon Ju Jeon et al.)
por: Jeon, Eon Ju, et al.
Publicado: (2014)

Letter: Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation (Endocrinol Metab 2014;29:33-9, Eon Ju Jeon et al.)
por: Jung, Chan-Hee
Publicado: (2014)

Ci siamo!
Publicado: (2008)

Thyroid and Breast Cancer in 2 Sisters With Monoallelic Mutations in the Ataxia Telangiectasia Mutated (ATM) Gene
por: Miasaki, Fabíola Y, et al.
Publicado: (2022)

Choosing Wisely for Thyroid Conditions: Recommendations of the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism
por: Dora, Jose Miguel, et al.
Publicado: (2021)

An MRI-Derived Definition of MCI-to-AD Conversion for Long-Term, Automatic Prognosis of MCI Patients
por: Aksu, Yaman, et al.
Publicado: (2011)

Microcystin mcyA and mcyE Gene Abundances Are Not Appropriate Indicators of Microcystin Concentrations in Lakes
por: Beversdorf, Lucas J., et al.
Publicado: (2015)

CiTO, the Citation Typing Ontology
por: Shotton, David
Publicado: (2010)

Che ci faccio qui?
por: Chatwin, Bruce, 1940-1989

Il Cern ci riprova
Publicado: (2009)

Treating Hyperthyroidism with Radioactive Iodine
por: Harding, L K
Publicado: (1993)

Radioactive iodine and female fertility
por: Navarro, Pino, et al.
Publicado: (2022)

Measuring clinical progression in MCI and pre-MCI populations: enrichment and optimizing clinical outcomes over time
por: Hendrix, Suzanne B
Publicado: (2012)

Engineering Nt.BtsCI and Nb.BtsCI nicking enzymes and applications in generating long overhangs
por: Too, Priscilla Hiu-Mei, et al.
Publicado: (2010)

Using EuGeneCiD and EuGeneCiM computational tools for synthetic biology
por: Schroeder, Wheaton L., et al.
Publicado: (2021)

CiXTH29 and CiLEA4 Role in Water Stress Tolerance in Cichorium intybus Varieties
por: De Caroli, Monica, et al.
Publicado: (2023)

The paradox of opposite directions of gene expressions in MCI and AD suggests possible therapy to prevent progression of MCI to AD
por: Fessel, Jeffrey
Publicado: (2020)

Approach to adult patients with primary hypothyroidism in some special situations: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism (SBEM)
por: Mazeto, Gláucia Maria Ferreira da Silva, et al.
Publicado: (2022)

Deploying to CVMFS via Gitlab-CI
por: Sailer, Andre, et al.
Publicado: (2018)

Static Code Analysis with Gitlab-CI
por: Datko, Szymon Tomasz
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_991f8nvr85hfrsfn7bmpa4b680